Posted on 31/07/03
Biovail slumps as Street backs away
TORONTO -- Biovail Corp. shares slumped for a second consecutive day, as some of the drug maker's staunchest supporters on Bay Street downgraded the stock and reduced their price targets in line with several U.S. analysts that moved on Tuesday.
The full text of this article has 708 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
